Evidence of sustained benefits of pimavanserin for dementia-related psychosis ...Middle East

A new paper published in the New England Journal of Medicine outlines a clinical trial, conducted in 392 people with psychosis associated with Alzheimer's disease, Parkinson's disease, Lewy body, frontotemporal, or vascular dementia. All participants were given pimavanserin for 12 weeks. Those who met a threshold of symptom improvement were then assigned to pimavanserin or placebo for up to 26 weeks.

Hence then, the article about evidence of sustained benefits of pimavanserin for dementia related psychosis was published today ( Thursday 22/07/2021 - 01:01 AM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Evidence of sustained benefits of pimavanserin for dementia-related psychosis )

Also on site :

• Retired Gen. Wesley Clark tangled up in a crypto fraud suit with Burning Man buddies
• My Friend Invited Us for Dinner. When She Greeted Us at the Door, She Asked for Something Shocking.
• Iconic '80s Boy Band Impresses With 'Amazing' Live Performance